SCHEMBL14334656

SCHEMBL14334656

O=C(O)N1CCN(C2CCN(C(=O)OCc3ccccc3)CC2)C(=O)C1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.58
NPC1 O15118 2/20 0.58
RAB9A P51151 2/20 0.58
CYP2C19 P33261 1/20 0.56
HDAC1 Q13547 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
GRIN2B Q13224 9/20 0.48
HTT P42858 1/20 0.48
CYP2D6 P10635 4/20 0.47
CYP2C9 P11712 4/20 0.47
CYP3A4 P08684 3/20 0.45
ENPP2 Q13822 1/20 0.44
HTR1A P08908 1/20 0.44
ADRA2C P18825 1/20 0.44
HRH2 P25021 1/20 0.44
HRH1 P35367 1/20 0.44
TMEM97 Q5BJF2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31461542 0.90 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9ACYP2C19HDAC1
SCHEMBL28435744 0.88 SMN1; SMN2 (0.54) SMN1; SMN2NPC1RAB9ACYP2C19MEN1
SCHEMBL2851491 0.87 SMN1; SMN2 (0.57) SMN1; SMN2NPC1RAB9ACYP2C19HDAC1
SCHEMBL12526593 0.87 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9ACYP2C19HDAC1
SCHEMBL30368837 0.87 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9ACYP2C19HDAC1
SCHEMBL3069766 0.83 SMN1; SMN2 (0.54) SMN1; SMN2NPC1RAB9ACYP2C19MEN1
SCHEMBL6969799 0.83 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9ACYP2C19HDAC1
SCHEMBL18756737 0.83 SMN1; SMN2 (0.47) SMN1; SMN2NPC1RAB9ACYP2C19HDAC1
SCHEMBL30283170 0.82 HTR2C (0.52) SMN1; SMN2NPC1RAB9ACYP2C19MEN1
SCHEMBL4872217 0.82 SMN1; SMN2 (0.60) SMN1; SMN2NPC1RAB9ACYP2C19HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012176123-A1 3 - IMIDAZOLYL- INDOLES FOR THE TREATMENT OF PROLIFERATIVE DISEASES NOVARTIS AG (CH) 2012-12-27 WO disclosed